Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-65
Closed -$2.51K 342
2024
Q2
$2.51K Hold
65
﹤0.01% 564
2024
Q1
$2.77K Buy
65
+1
+2% +$41 ﹤0.01% 561
2023
Q4
$2.38K Buy
64
+1
+2% +$36 ﹤0.01% 560
2023
Q3
$2.3K Hold
63
﹤0.01% 538
2023
Q2
$2.24K Buy
63
+1
+2% +$36 ﹤0.01% 542
2023
Q1
$2.22K Sell
62
-36
-37% -$1.26K ﹤0.01% 520
2022
Q4
$3.43K Sell
98
-160
-62% -$5.33K ﹤0.01% 450
2022
Q3
$7.59K Sell
258
-80
-24% -$3.03K ﹤0.01% 350
2022
Q2
$18.4K Buy
338
+241
+248% +$13.3K 0.01% 262
2022
Q1
$5.26K Buy
97
+1
+1% +$54 ﹤0.01% 424
2021
Q4
$5.29K Buy
96
+38
+66% +$1.98K ﹤0.01% 431
2021
Q3
$2.79K Sell
58
-2,240
-97% -$113K ﹤0.01% 480
2021
Q2
$72K Buy
2,298
+2,241
+3,932% +$108K ﹤0.01% 417
2021
Q1
$2.53K Buy
57
+1
+2% +$45 ﹤0.01% 483
2020
Q4
$2.58K Sell
56
-10
-15% -$459 ﹤0.01% 441
2020
Q3
$3.12K Hold
66
﹤0.01% 392
2020
Q2
$3.39K Hold
66
﹤0.01% 376
2020
Q1
$3.15K Hold
66
﹤0.01% 348
2019
Q4
$3.9K Hold
66
﹤0.01% 335
2019
Q3
$3.54K Buy
+66
New +$3.4K ﹤0.01% 333

Other funds holding GSK

Kelly Financial Services's GSK Position: Q3 2024 in Review

Kelly Financial Services sold out of GSK (GSK) in Q3 2024, closing a stake of 65 shares — an estimated $2.51K sold.

Kelly Financial Services first reported a position in GSK in Q3 2019 and held it in 20 quarters. The position peaked at $72K in Q2 2021. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Kelly Financial Services reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Kelly Financial Services sold 65 GSK shares in Q3 2024, an estimated $2.51K.
  • Kelly Financial Services first reported a position in GSK in Q3 2019 and held it in 20 quarters.
  • Kelly Financial Services's GSK position peaked at $72K in Q2 2021.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Kelly Financial Services's 13F filing for Q3 2024, filed 9 Oct 2024.